Skip to main content
. 2020 Sep 4;12(9):2516. doi: 10.3390/cancers12092516

Table 2.

Evaluation of the PD-L1 expression with the tumor proportional score (TPS).

TPS Category PD-L1 Expression in Tumors Number of Patients (%)
0 <1% 20 (37.0)
1 ≥1% to <5% 10 (18.5)
2 ≥5% to <10% 6 (11.1)
3 ≥10% to <25% 7 (13.0)
4 ≥25% to <50% 6 (11.1)
5 ≥50% 4 (7.4)
- Unknown/not assessable 1 (1.9)